Antigens, Neoplasm

"Antigens, Neoplasm" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Proteins, glycoprotein, or lipoprotein moieties on surfaces of tumor cells that are usually identified by monoclonal antibodies. Many of these are of either embryonic or viral origin.

Descriptor ID	D000951
MeSH Number(s)	D23.050.285
Concept/Terms	Antigens, Neoplasm Antigens, Neoplasm Neoplasm Antigens Tumor Antigens Tumor Antigens Antigens, Tumor

Below are MeSH descriptors whose meaning is more general than "Antigens, Neoplasm".

Chemicals and Drugs [D]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Neoplasm [D23.050.285]

Below are MeSH descriptors whose meaning is related to "Antigens, Neoplasm".

Below are MeSH descriptors whose meaning is more specific than "Antigens, Neoplasm".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Antigens, Neoplasm" by people in this website by year, and whether "Antigens, Neoplasm" was a major or minor topic of these publications.

Bar chart showing 69 publications over 21 distinct years, with a maximum of 6 publications in 2006 and 2016

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2002	1	0	1
2003	1	1	2
2004	2	1	3
2005	0	1	1
2006	4	2	6
2007	5	0	5
2008	4	1	5
2009	3	0	3
2010	2	1	3
2011	3	0	3
2012	2	1	3
2013	3	1	4
2014	5	0	5
2015	2	2	4
2016	4	2	6
2017	2	1	3
2018	1	1	2
2019	0	3	3
2020	1	1	2
2022	1	1	2
2025	2	1	3

Below are the most recent publications written about "Antigens, Neoplasm" by people in Profiles.

D'Alise AM, Willis J, Duzagac F, Hall MJ, Cruz-Correa M, Idos GE, Thirumurthi S, Ballester V, Leoni G, Garzia I, Antonucci L, De Marco L, Micarelli E, Deng N, Secl? L, Gogov S, Dong W, Jack Lee J, Bowen CM, Vornik LA, Garcia-Gonzalez A, Reyes-Uribe L, Richmond E, Umar A, Brown PH, Sinha KM, Rodriguez LM, Scarselli E, Vilar E. Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial. Nat Med. 2026 Mar; 32(3):1002-1011.

View in: PubMed
Xiong Z, Kong Q, Chagantipati B, Stepniak A, Jaswal AP, Sneiderman CT, Han Y, Jackson SA, Raphael RA, Zhang W, Li M, Chao Y, Qin B, Dulkadir Z, Schwegman L, Zhang Y, Kuminkoski C, Mahlke MA, Nath P, Hu B, Zinn PO, Mantica M, Agnihotri S, Nechemia-Arbely Y, Pollack IF, Rigatti LH, Forsthuber TG, Li X, Raphael I, Kohanbash G. C/EBP?-induced alternative splicing of RCAN1 generates a potent TCR-T target in mesenchymal glioblastoma. Cell Mol Immunol. 2026 Jan; 23(1):94-113.

View in: PubMed
Qiu C, Wang X, Francia G, Casiano CA, Zhang JY. A panel of four autoantibodies to tumour-associated antigens in patients with prostate cancer and its potential for multi-cancer detection. Br J Cancer. 2026 Feb; 134(3):493-503.

View in: PubMed
Castillo MB, Rankothgedera S, Thevasagayampillai S, Kandasamy A, Lewis J, Woody C, Vaz de Freitas M, Antunes DA, El-Zein R, Gunaratne PH. Identification of immunogenic KIF5B-RET fusion neopeptides driving immune stimulation in tumor specific CD8+ T cells. Front Immunol. 2025; 16:1635810.

View in: PubMed
Uzhachenko RV, Gonz?lez Ochoa S, Kanagasabai T, Rajakaruna H, Thounaojam MC, de Aquino MTP, Rana T, Costa L, Terekhov A, Hofmeister WH, Sayers TJ, Boyer C, Ivanova AV, Goodwin JS, Schmitt-Verhulst AM, Shanker A. CD8+ T-NK cell crosstalk establishes preemptive immunosurveillance to eliminate antigen-escape tumors. Front Immunol. 2025; 16:1593913.

View in: PubMed
Akbari B, Hasan MM, Islam SM. Advances in targeted therapy for triple-negative breast cancer: a review of key antigens and recent advances. J Drug Target. 2025 Nov; 33(9):1555-1574.

View in: PubMed
Xiong Z, Sneiderman CT, Kuminkoski CR, Reinheimer J, Schwegman L, Sever RE, Habib A, Hu B, Agnihotri S, Rajasundaram D, Zinn PO, Forsthuber TG, Pollack IF, Li X, Raphael I, Kohanbash G. Transcript-targeted antigen mapping reveals the potential of POSTN splicing junction epitopes in glioblastoma immunotherapy. Genes Immun. 2025 06; 26(3):190-199.

View in: PubMed
Raphael I, Xiong Z, Sneiderman CT, Raphael RA, Mash M, Schwegman L, Jackson SA, O'Brien C, Anderson KJ, Sever RE, Hendrikse LD, Vincze SR, Diaz A, Felker J, Nazarian J, Nechemia-Arbely Y, Hu B, Kammula US, Agnihotri S, Rich JN, Broniscer A, Drappatz J, Abel TJ, Uttam S, Hwang EI, Pearce TM, Taylor MD, Nisnboym M, Forsthuber TG, Pollack IF, Chikina M, Rajasundaram D, Kohanbash G. The T cell receptor landscape of childhood brain tumors. Sci Transl Med. 2025 Mar 19; 17(790):eadp0675.

View in: PubMed
Ma Y, Qiu C, Wang B, Zhang X, Wang X, Aguilera RJ, Zhang JY. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells. 2022 10 14; 11(20).

View in: PubMed
Beasley HK, Widatalla SE, Whalen DS, Williams SD, Korolkova OY, Namba C, Pratap S, Ochieng J, Sakwe AM. Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer. Front Endocrinol (Lausanne). 2022; 13:816598.

View in: PubMed

People

Explore

Similar Concepts

Top Journals